NCT01824498

Brief Summary

The primary objective of this investigation is to determine whether diets designed to increase plasma n3 concentrations (a low fat diet, with or without n3 fatty acid enrichment), will favorably affect sex hormone distribution in women in a direction associated with reduced risk of sex hormone-mediated cancer development. Specifically, we hypothesize that an increased concentration of circulating n3 fatty acids will reduce the biochemical markers associated with increased risk for developing certain sex hormone mediated cancers such as breast cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jan 2004

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 4, 2013

Completed
6 months until next milestone

Results Posted

Study results publicly available

September 25, 2013

Completed
Last Updated

August 31, 2018

Status Verified

August 1, 2018

Enrollment Period

4.9 years

First QC Date

April 1, 2013

Results QC Date

April 4, 2013

Last Update Submit

August 1, 2018

Conditions

Keywords

omega-3 fatty acidssex hormonesurinary sex hormone metabolites

Outcome Measures

Primary Outcomes (2)

  • Plasma Sex Hormone Levels

    8 weeks

  • E2

    Estradiol

    8 weeks

Study Arms (6)

Low Fat, High Fat, Low Fat High Omega 3

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

Low Fat, Low Fat High Omega 3, High Fat

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

High Fat, Low Fat, Low Fat High Omega 3

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

High Fat, Low fat High Omega 3, Low Fat

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

Low Fat High Omega 3, High Fat, Low Fat

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

Low Fat High Omega 3, Low Fat, High Fat

EXPERIMENTAL

See Intervention Description

Other: Low Fat dietOther: Low Fat high n3 dietOther: High Fat Diet

Interventions

Low fat diet = 20% fat

High Fat, Low Fat, Low Fat High Omega 3High Fat, Low fat High Omega 3, Low FatLow Fat High Omega 3, High Fat, Low FatLow Fat High Omega 3, Low Fat, High FatLow Fat, High Fat, Low Fat High Omega 3Low Fat, Low Fat High Omega 3, High Fat

Low Fat high n3 diet = 20% fat + 3% n3

High Fat, Low Fat, Low Fat High Omega 3High Fat, Low fat High Omega 3, Low FatLow Fat High Omega 3, High Fat, Low FatLow Fat High Omega 3, Low Fat, High FatLow Fat, High Fat, Low Fat High Omega 3Low Fat, Low Fat High Omega 3, High Fat

High Fat Diet = 40% fat

High Fat, Low Fat, Low Fat High Omega 3High Fat, Low fat High Omega 3, Low FatLow Fat High Omega 3, High Fat, Low FatLow Fat High Omega 3, Low Fat, High FatLow Fat, High Fat, Low Fat High Omega 3Low Fat, Low Fat High Omega 3, High Fat

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women
  • to 70 years old,
  • at least one year since their last menstrual period
  • not using hormone replacement therapy,
  • BMI between 19 -29
  • willingness to discontinue use of over-the-counter medications with anti-prostaglandin activity such as aspirin or non-steroidal anti-inflammatory medications
  • consumption of a "Typical " American diet with no unusual dietary practices such as compliance with a strict vegetarian diet
  • willingness to comply with the demands of the experimental protocol.

You may not qualify if:

  • Smoking
  • Known disease process, and 3) Use of prescription medications, including hormone replacement therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Related Publications (4)

  • McColley SP, Georgopoulos A, Young LR, Kurzer MS, Redmon JB, Raatz SK. A high-fat diet and the threonine-encoding allele (Thr54) polymorphism of fatty acid-binding protein 2 reduce plasma triglyceride-rich lipoproteins. Nutr Res. 2011 Jul;31(7):503-8. doi: 10.1016/j.nutres.2011.06.003.

    PMID: 21840466BACKGROUND
  • Raatz SK, Young LR, Picklo MJ Sr, Sauter ER, Qin W, Kurzer MS. Total dietary fat and fatty acid content modifies plasma phospholipid fatty acids, desaturase activity indices, and urinary prostaglandin E in women. Nutr Res. 2012 Jan;32(1):1-7. doi: 10.1016/j.nutres.2011.12.006.

    PMID: 22260857BACKGROUND
  • Young LR, Raatz SK, Thomas W, Redmon JB, Kurzer MS. Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women. Nutr Metab (Lond). 2013 Apr 23;10(1):36. doi: 10.1186/1743-7075-10-36.

    PMID: 23618064BACKGROUND
  • Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer. 2011;63(6):930-9. doi: 10.1080/01635581.2011.589957. Epub 2011 Jul 11.

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Diet, Fat-RestrictedDiet, High-Fat

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Results Point of Contact

Title
Susan Raatz, PhD, RD
Organization
USDA, GFHNRC

Study Officials

  • Susan K Raatz, PhD, RD

    USDA, GFHNRC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2013

First Posted

April 4, 2013

Study Start

January 1, 2004

Primary Completion

December 1, 2008

Study Completion

November 1, 2010

Last Updated

August 31, 2018

Results First Posted

September 25, 2013

Record last verified: 2018-08

Locations